ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
200.29
+1.69 (0.85%)
At close: Jun 26, 2026, 4:00 PM EDT
201.00
+0.71 (0.35%)
After-hours: Jun 26, 2026, 7:40 PM EDT
ResMed Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for ResMed stock have an average target of 256.09, with a low estimate of 225 and a high estimate of 321. The average target predicts an increase of 27.86% from the current stock price of 200.29.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ResMed stock from 19 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 7 | 9 | 9 |
| Buy | 3 | 3 | 3 | 3 | 2 | 1 |
| Hold | 7 | 7 | 7 | 7 | 7 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 19 | 19 | 19 | 18 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 22, 2026 |
| KeyBanc | KeyBanc | Buy Reiterates $290 → $266 | Buy | Reiterates | $290 → $266 | +32.81% | Jun 22, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Downgrades $286 → $230 | Hold | Downgrades | $286 → $230 | +14.83% | Jun 17, 2026 |
| Citi | Citi | Buy Reiterates $340 → $270 | Buy | Reiterates | $340 → $270 | +34.80% | Jun 15, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $320 | Buy | Reiterates | $320 | +59.77% | Jun 4, 2026 |
Financial Forecast
Revenue This Year
5.65B
from 5.15B
Increased by 9.81%
Revenue Next Year
6.10B
from 5.65B
Increased by 7.87%
EPS This Year
11.11
from 9.55
Increased by 16.34%
EPS Next Year
12.10
from 11.11
Increased by 8.94%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.7B | 6.2B | |
| Avg | 5.7B | 6.1B | |
| Low | 5.6B | 6.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.5% | 10.0% | |
| Avg | 9.8% | 7.9% | |
| Low | 9.3% | 7.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.20 | 12.36 | |
| Avg | 11.11 | 12.10 | |
| Low | 10.98 | 11.97 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.3% | 11.2% | |
| Avg | 16.3% | 8.9% | |
| Low | 15.0% | 7.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.